Caxton Associates LP Sangamo Therapeutics, Inc Transaction History

Caxton Associates LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.11 - $1.74 $122,386 - $191,848	-110,258 Reduced 38.26%	177,960 $231,000
Q1 2023 May 15, 2023	BUY	$1.66 - $3.67 $204,420 - $451,942	123,145 Added 74.6%	288,218 $507,000
Q4 2022 Feb 14, 2023	BUY	$2.77 - $5.07 $457,252 - $836,920	165,073 New	165,073 $518,000
Q1 2022 May 16, 2022	BUY	$5.23 - $7.82 $463,111 - $692,453	88,549 New	88,549 $514,000

111

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.